Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria
Abstract Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH) in liver resulting in blood phenylalanine (Phe) elevation and neurotoxicity. A pegylated phenylalanine ammonia lyase (PEG-PAL) metabolizing Phe into cinnamic acid was recently approved as treatment for PKU pati...
Guardado en:
Autores principales: | Rachna Manek, Yao V. Zhang, Patricia Berthelette, Mahmud Hossain, Cathleen S. Cornell, Joseph Gans, Gulbenk Anarat-Cappillino, Sarah Geller, Robert Jackson, Dan Yu, Kuldeep Singh, Sue Ryan, Dinesh S. Bangari, Ethan Y. Xu, Sirkka R. M. Kyostio-Moore |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3a454c49a4a458db2c91e87d25ee520 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria
por: Kuldeep Singh, et al.
Publicado: (2021) -
Improving phenylalanine and micronutrients status of children with phenylketonuria: a pilot randomized study
por: Reza Zamani, et al.
Publicado: (2021) -
Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
por: Iris Scala, et al.
Publicado: (2021) -
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride
por: Cary O Harding
Publicado: (2010) -
Italian national consensus statement on management and pharmacological treatment of phenylketonuria
por: Alberto Burlina, et al.
Publicado: (2021)